| Application no. and date | 06760628.5 (espacenet) (Federated) (European Patent Register), 20060602 | | Patent/reg. no. and date | DK/EP 1893213, 20100217 | | Publication date | 20080305 | | Priority no. and date | US 687758 P, 20050603 | | EP pub. no. and date |
EP 1893213 20080305 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 138362 | | Inventor | MANLEY, Paul, W., Bruggweg 12
CH-4144 Arlesheim, CH,
MESTAN, Juergen, Zugmantelstrasse 6
79211 Denzlingen, DE,
ALLAND, Leila, 129 Noe Avenue
Chatham, New Jersey 07928, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombination af pyrimidylaminobenzamidforbindelser og imatinib til behandling eller forebyggelse af proliferative sygdomme | | Int. application no. | US2006021307 | | Int. publication no. | WO2006132930 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
